Sarentha Chetty

Dr. Sarentha Chetty

University of the Witwatersrand, Johannesburg, Gauteng, South Africa
+1

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SCSarentha Chetty
Sarentha Chetty
MRMuthusamy Ramesh
Muthusamy Ramesh
ASAshona Singh-Pillay
Ashona Singh-Pillay
Mahmoud SolimanMahmoud Soliman
Mahmoud Soliman

28 November 2019 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PDF file
SCSarentha Chetty
Sarentha Chetty
MRMillidhashni Reddy
Millidhashni Reddy
YRYogandree Ramsamy
Yogandree Ramsamy
ANAnushka Naidoo
Anushka Naidoo
SESabiha Yusuf Essack
Sabiha Yusuf Essack
To map published data of antimicrobial stewardship (AMS) interventions that are currently being carried out in hospitals and clinics in the public and private health sectors of South Africa in line with the antimicrobial resistance (AMR) strategy of South Africa. A systematic scoping review was conducted to identify AMS initiatives in the public and private health sectors of South Africa for the period 1 January 2000 to 31 March 2019. An electronic search of databases was made including PubMed, Scopus, a key medical journal (South African Medical Journal), University of KwaZulu-Natal (UKZN) WorldCat iCatalogue and AMR networks: Federation of Infectious Diseases Societies in South Africa (FIDSSA). Reference lists of published articles were also reviewed for inclusion. Keywords included ‘antimicrobial antibiotic stewardship South Africa’. Of a total of 411 articles, using a stepwise screening process, 18 articles were selected for inclusion in the review. The interventions/initiatives were divided into four broad categories: (i) AMS intervention: prescription audits and usage; (ii) AMS intervention: education and its impact; (iii) other AMS interventions; and (iv) the role of different healthcare professionals in AMS. The data identifies a need for and the value of AMS in both the public and private health sectors of South Africa. Initiatives are carried out across both sectors but more attention needs to be focused on AMS implementation in line with the National AMR Strategy of South Africa. Collaboration between the different sectors will aid in overcoming the AMR challenge.

17 December 2022 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
JMJon-Benay Mitchell
Jon-Benay Mitchell
SCSarentha Chetty
Sarentha Chetty
FKFatima Kathrada
Fatima Kathrada
Background: Endometriosis is a complex chronic disease that affects approximately 10% of women of reproductive age worldwide and commonly presents with pelvic pain and infertility. Method & outcome measures: A systematic review of the literature was carried out using the databases Pubmed, Scopus, Cochrane and ClinicalTrials.gov in women with a confirmed laparoscopic diagnosis of endometriosis receiving progestins to determine a reduction in pain symptoms and the occurrence of adverse effects. Results: Eighteen studies were included in the meta-analysis. Progestins improved painful symptoms compared to placebo (SMD = −0.61, 95% CI (−0.77, −0.45), P < 0.00001) with no comparable differences between the type of progestin. After median study durations of 6–12 months, the median discontinuation rate due to adverse effects was 0.3% (range: 0 − 37.1%) with mild adverse effects reported. Conclusion: The meta-analysis revealed that pain improvement significantly increased with the use of progestins with low adverse effects. Systematic Review Registration: PROSPERO CRD42021285026.

14 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SCSarentha Chetty
Sarentha Chetty
TATom Armstrong
Tom Armstrong
SKShalu Sharma Kharkwal
Shalu Sharma Kharkwal
WDWilliam C. Drewe
William C. Drewe
CMCristina I. De Matteis
Cristina I. De Matteis
NTNeil R. Thomas
Neil R. Thomas
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has reinforced the need for the development of new anti-TB drugs. The first line drug isoniazid inhibits InhA. This is a prodrug requiring activation by the enzyme KatG. Mutations in KatG have largely contributed to clinical isoniazid resistance. We aimed to design new ‘direct’ InhA inhibitors that obviate the need for activation by KatG, circumventing pre-existing resistance. In silico molecular modelling was used as part of a rational structure-based drug-design approach involving inspection of protein crystal structures of InhA:inhibitor complexes, including the broad spectrum antibiotic triclosan (TCS). One crystal structure exhibited the unusual presence of two triclosan molecules within the Mycobacterium tuberculosis InhA binding site. This became the basis of a strategy for the synthesis of novel inhibitors. A series of new, flexible ligands were designed and synthesised, expanding on the triclosan structure. Low Minimum Inhibitory Concentrations (MICs) were obtained for benzylphenyl compounds (12, 43 and 44) and di-triclosan derivative (39), against Mycobacterium bovis BCG although these may also be inhibiting other enzymes. The ether linked di-triclosan derivative (38) displayed excellent in vitro isolated enzyme inhibition results comparable with triclosan, but at a higher MIC (125 µg mL−1). These compounds offer good opportunities as leads for further optimisation.

5 March 2024 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PDF file
SCSarentha Chetty
Sarentha Chetty
KSKhine Swe Swe-Han
Khine Swe Swe-Han
YMYesholata Mahabeer
Yesholata Mahabeer
APAshendri Pillay
Ashendri Pillay
SESabiha Yusuf Essack
Sabiha Yusuf Essack
Antimicrobial stewardship (AMS) education and interprofessional collaboration are integral to the success of a stewardship programme. An interactive interprofessional AMS workshop, designed to encourage workplace interprofessional collaboration was piloted in a tertiary hospital. To obtain feedback to determine the suitability and sustainability of the AMS workshop. Feedback was elicited through a predesigned questionnaire containing both open-ended and closed questions on the content and structure of the workshop. The survey had a 70% (n = 16) overall response rate. All participants agreed that the goals of the workshop were met and that the knowledge and skills gained from the workshop would help them in their AMS roles. All participants indicated that the workshop content, and the level at which it was pitched, met their expectations and that it had improved their knowledge and skills. All agreed that they found it advantageous and enjoyed learning as an interprofessional group. Open feedback showed that the workshop was found to be useful and would potentially result in improved patient care, dissemination of knowledge, improved teamwork and organizational culture. The positive feedback and changes made following the workshop demonstrated that a targeted AMS educational workshop adds value to an antimicrobial stewardship programme.